Skip Navigation



European Heart Journal Advance Access published online on December 15, 2004
European Heart Journal, doi:10.1093/eurheartj/ehi077
This Article
Right arrow Full Text (Rapid PDF)
Right arrow All Versions of this Article:
26/3/210    most recent
ehi077v1
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Walldius, G.
Right arrow Articles by Jungner, I.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Walldius, G.
Right arrow Articles by Jungner, I.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

European Heart Journal © The European Society of Cardiology 2004; all rights reserved

Editorial

Rationale for using apolipoprotein B and apolipoprotein A-I as indicators of cardiac risk and as targets for lipid-lowering therapy

Göran Walldius 1* and Ingmar Jungner 2

1 King Gustaf V Research Institute, Karolinska Institute, Stockholm, Sweden; AstraZeneca, Mölndal, Sweden
2 Karolinska Institute, Department of Medicine, Clinical Epidemiology Unit, Stockholm, Sweden; CALAB Research, Stockholm, Sweden

* To whom correspondence should be addressed.
Göran Walldius, E-mail: goran.walldius{at}astrazeneca.com



This article has no Abstract.
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 J. Nutr.Home page
E. A. Pipe, C. P. Gobert, S. E. Capes, G. A. Darlington, J. W. Lampe, and A. M. Duncan
Soy Protein Reduces Serum LDL Cholesterol and the LDL Cholesterol:HDL Cholesterol and Apolipoprotein B:Apolipoprotein A-I Ratios in Adults with Type 2 Diabetes
J. Nutr., September 1, 2009; 139(9): 1700 - 1706.
[Abstract] [Full Text] [PDF]

Home page
 Eur Heart JHome page
J. Sierra-Johnson, R. M. Fisher, A. Romero-Corral, V. K. Somers, F. Lopez-Jimenez, J. Ohrvik, G. Walldius, M.-L. Hellenius, and A. Hamsten
Concentration of apolipoprotein B is comparable with the apolipoprotein B/apolipoprotein A-I ratio and better than routine clinical lipid measurements in predicting coronary heart disease mortality: findings from a multi-ethnic US population
Eur. Heart J., March 2, 2009; 30(6): 710 - 717.
[Abstract] [Full Text] [PDF]

Home page
 Br. J. Sports. Med.Home page
G M Perkins, A Owen, E M Kearney, and I L Swaine
Biomarkers of cardiovascular disease risk in 40-65-year-old men performing recommended levels of physical activity, compared with sedentary men
Br. J. Sports Med., February 1, 2009; 43(2): 136 - 141.
[Abstract] [Full Text] [PDF]

Home page
 J. Am. Coll. Nutr.Home page
M. L. Fernandez and D. Webb
The LDL to HDL Cholesterol Ratio as a Valuable Tool to Evaluate Coronary Heart Disease Risk
J. Am. Coll. Nutr., February 1, 2008; 27(1): 1 - 5.
[Abstract] [Full Text] [PDF]

Home page
 Eur Heart JHome page
J. Sierra-Johnson, A. Romero-Corral, V. K. Somers, F. Lopez-Jimenez, G. Walldius, A. Hamsten, M.-L. Hellenius, and R. M. Fisher
ApoB/apoA-I ratio: an independent predictor of insulin resistance in US non-diabetic subjects
Eur. Heart J., November 1, 2007; 28(21): 2637 - 2643.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes and Vascular Disease ResearchHome page
B. Goke, I. Gause-Nilsson, and A. Persson
The effects of tesaglitazar as add-on treatment to metformin in patients with poorly controlled type 2 diabetes
Diabetes and Vascular Disease Research, September 1, 2007; 4(3): 204 - 213.
[Abstract] [PDF]

Home page
 CirculationHome page
C. B. Ingul, E. Rozis, S. A. Slordahl, and T. H. Marwick
Incremental Value of Strain Rate Imaging to Wall Motion Analysis for Prediction of Outcome in Patients Undergoing Dobutamine Stress Echocardiography
Circulation, March 13, 2007; 115(10): 1252 - 1259.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
F. Lanas, A. Avezum, L. E. Bautista, R. Diaz, M. Luna, S. Islam, S. Yusuf, and for the INTERHEART Investigators in Latin America
Risk Factors for Acute Myocardial Infarction in Latin America: The INTERHEART Latin American Study
Circulation, March 6, 2007; 115(9): 1067 - 1074.
[Abstract] [Full Text] [PDF]

Home page
 Journals of Gerontology Series A: Biological Sciences and Medical SciencesHome page
G. Florvall, S. Basu, and A. Larsson
Apolipoprotein A1 Is a Stronger Prognostic Marker Than Are HDL and LDL Cholesterol for Cardiovascular Disease and Mortality in Elderly Men
J. Gerontol. A Biol. Sci. Med. Sci., December 1, 2006; 61(12): 1262 - 1266.
[Abstract] [Full Text] [PDF]

Home page
 J. Epidemiol. Community HealthHome page
K M Nielsen, O Faergeman, M L Larsen, and A Foldspang
Danish singles have a twofold risk of acute coronary syndrome: data from a cohort of 138 290 persons.
J Epidemiol Community Health, August 1, 2006; 60(8): 721 - 728.
[Abstract] [Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.